Answers are grounded in this paper and cite their sources.
New potential therapeutic uses for FMT have created a demand for stricter exclusion criteria for donors. This study illustrates that screening many individuals to find a donor and the subsequent associated costs may make central processing and shipment a more reasonable alternative.
No takes yet. Share an insight, caveat, or question.
Craven et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: